about
ADAM2 interactions with mouse eggs and cell lines expressing α4/α9 (ITGA4/ITGA9) integrins: implications for integrin-based adhesion and fertilizationDominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancerMicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenibMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentSelecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsmiR-1247 functions by targeting cartilage transcription factor SOX9Preferred SH3 domain partners of ADAM metalloproteases include shared and ADAM-specific SH3 interactions.A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implicationsADAM-17: the enzyme that does it all.ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.Neisseria gonorrhoeae infection induces altered amphiregulin processing and releaseIdentification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells.miR-221/222 control luminal breast cancer tumor progression by regulating different targets.ADAM15 exerts an antiapoptotic effect on osteoarthritic chondrocytes via up-regulation of the X-linked inhibitor of apoptosis.Functional protease profiling for diagnosis of malignant disease.Systemic overexpression of TNFα-converting enzyme does not lead to enhanced shedding activity in vivoOverexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.A global microRNA screen identifies regulators of the ErbB receptor signaling network.Molecular genetic study of novel biomarkers for early diagnosis of oral squamous cell carcinomaPlasma membrane microdomains regulate TACE-dependent TNFR1 shedding in human endothelial cells.ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder CancermRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.ADAM10: a new player in breast cancer progression?Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancerInsights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7)Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.Expression of Migration-Related Genes in Human Colorectal Cancer and Activity of a Disintegrin and Metalloproteinase 17.Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.ADAM Proteases and Gastrointestinal Function.The ADAMs family of proteases as targets for the treatment of cancer.ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.The role of Adams in Notch signaling.P95 HER2 fragments and breast cancer outcome.Triple-negative breast cancer: investigating potential molecular therapeutic target.Impact of proteolytic enzymes in colorectal cancer development and progression.Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activitiesCombined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer.miR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9.
P2860
Q24306366-175AE087-7F88-4E56-9F5F-9B6652E9818EQ24337644-E4B40DB0-8832-4D88-8790-7E16048B15ACQ24655048-94D46AB5-902A-49BD-878D-45C9D9E5E033Q28073613-33F01CF3-9DEB-4748-83F8-1659992BBD6BQ28077999-BF371616-EE3D-4705-A39F-A0093F544E80Q28587159-31DD18AF-9AA3-40A2-9469-3BE74B569641Q30009199-E0774BD7-6768-4A0D-A51C-4997A2F26DCAQ30430629-8AE91FF8-F218-421B-A93A-79AC6CE32106Q33737421-4B96A884-DCBA-4DAA-AA62-CC529909A892Q33794994-358E1754-BBAD-4161-9227-C619D56EC3E8Q33813182-8F20D92D-D6EC-4DDF-95F9-B1E92FAD0319Q33940945-CD36BABD-BEE2-40F7-AE15-0BB86932BF49Q33952998-D6491994-E302-4D58-B0A2-F2A114465E5CQ34102868-0FDE0533-D35E-4189-A608-DEAD545CFBBBQ34116114-F80AB740-C050-43ED-9D24-6F2012B9AE4CQ34559443-4B86AF0D-0282-41BF-8BAB-D1584F5439C0Q34577446-FE455CB5-2435-4D02-95C7-EBD936B0E9BEQ34993968-19E418D2-276D-4DB4-A494-B9D1CA93E04FQ35041481-831ABE00-68DD-4528-BCC4-72674C43F199Q35374065-42BC6F63-2E83-4394-8805-4FBC14E13491Q35456998-9B17E454-4EB2-48D0-8785-286C0356B389Q35941467-154CAD1D-4AAC-4E4D-BAED-D02693F1BDB1Q36075298-A29690D7-42F4-4941-B784-7237FDF0FEEDQ36081396-EFE9B1E1-3AFF-4440-A708-F8D96EE750B4Q36086816-54E370A2-8B86-4241-B754-22CBD0576BFFQ36315707-9CF0145C-EDA4-472E-95F7-397BEA55E003Q36451958-17B88C25-ADE7-4439-8D52-55CE0D3C1853Q36589865-CC65C161-3765-481C-B2EA-698A8B43E9DAQ36783910-F4673562-BE39-4317-AB86-49C33B4830CBQ36926842-597E052A-51EB-449F-BFAA-F4AE1F78084CQ37052477-0DBC8EE4-CF08-4BD3-8918-88A47DEF5C54Q37216972-247AA374-CC6C-401B-B2FF-583F271448DBQ37591124-A476FAC0-0DF9-47A7-BD77-66455B3CB8E8Q37991568-6589DB0C-026F-44F9-873B-189ED1415585Q38223511-6A76AC2E-6A7F-41F1-BDA7-9D5405A05FD9Q38259322-F5FABEC0-F99C-450F-87FD-D55DEA329346Q38259533-1BE190EA-E93C-414E-9E40-470E8E6FAAC0Q38431347-C97495AB-C1DB-4BD1-87C2-572120486E04Q38792740-53A09E6C-532D-4627-8CBB-4C14853E2EF4Q38957321-F60B51A0-623A-4E4D-BB96-4A4A14C5DF60
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Role of ADAMs in cancer formation and progression.
@ast
Role of ADAMs in cancer formation and progression.
@en
type
label
Role of ADAMs in cancer formation and progression.
@ast
Role of ADAMs in cancer formation and progression.
@en
prefLabel
Role of ADAMs in cancer formation and progression.
@ast
Role of ADAMs in cancer formation and progression.
@en
P1476
Role of ADAMs in cancer formation and progression.
@en
P2093
Eadaoin McKiernan
Michael J Duffy
P304
P356
10.1158/1078-0432.CCR-08-1585
P407
P577
2009-02-01T00:00:00Z